Abstract
In a cultured human hepatoblastoma cell line, Hep G2, chenodeoxycholic acid (CDCA) induced LDL receptor mRNA levels approximately 4 fold and mRNA levels for HMG-CoA reductase and HMG-CoA synthase two fold. In contrast, the mRNA levels for mevalonate kinase, farnesyl pyrophosphate synthase and squalene synthase were not changed significantly. The pattern of the induction of the sterol-sensitive genes was similar to the induction by N-acetyl-leucyl-leucyl-norleucinal (ALLN), an SREBP degradation inhibitor, suggesting that CDCA may increase mature SREBPs. CDCA could inhibit the 25-hydroxycholesterol mediated inactivation of SREBP without affecting mRNA levels of SREBPs. These results suggest that CDCA can affect sterol metabolism by a novel mechanism involving the inhibition of the oxysterol-mediated inactivation of SREBP.
MeSH terms
-
Alkyl and Aryl Transferases*
-
Base Sequence
-
Cell Line
-
Chenodeoxycholic Acid / pharmacology*
-
Codon
-
DNA-Binding Proteins / metabolism
-
Farnesyl-Diphosphate Farnesyltransferase / biosynthesis
-
Gene Expression / drug effects
-
Geranyltranstransferase
-
Hepatoblastoma
-
Humans
-
Hydroxycholesterols / pharmacology
-
Hydroxymethylglutaryl CoA Reductases / biosynthesis*
-
Hydroxymethylglutaryl-CoA Synthase / biosynthesis*
-
Leupeptins / pharmacology
-
Liver Neoplasms
-
Phosphotransferases (Alcohol Group Acceptor) / biosynthesis
-
Protease Inhibitors / pharmacology
-
RNA, Messenger / analysis
-
RNA, Messenger / biosynthesis
-
Receptors, LDL / biosynthesis*
-
Regulatory Sequences, Nucleic Acid
-
Transferases / biosynthesis
-
Tumor Cells, Cultured
Substances
-
Codon
-
DNA-Binding Proteins
-
Hydroxycholesterols
-
Leupeptins
-
Protease Inhibitors
-
RNA, Messenger
-
Receptors, LDL
-
Chenodeoxycholic Acid
-
acetylleucyl-leucyl-norleucinal
-
25-hydroxycholesterol
-
Hydroxymethylglutaryl CoA Reductases
-
Transferases
-
Hydroxymethylglutaryl-CoA Synthase
-
Alkyl and Aryl Transferases
-
Geranyltranstransferase
-
Farnesyl-Diphosphate Farnesyltransferase
-
Phosphotransferases (Alcohol Group Acceptor)
-
mevalonate kinase